Drugs / Adipose Tissue Mesenchymal Stromal Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07544537 | Sep 2024 → Jan 2026 overdue | erectile dysfunction | National Scientific Medical Center, Kazakhstan | Active not recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adipose Tissue Mesenchymal Stromal Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07544537 ↗ |
| Known as | ADSC | “Adipose Tissue Mesenchymal Stromal Cells (ADSC)” NCT07544537 ↗ |
| Modality | Cell therapy | “autologous mesenchymal stem cells derived from bone marrow or adipose tissue” NCT07544537 ↗ |
| Route | Other | “A single intracavernosal injection of at least 25 x 10⁶ autologous adipose tissue-derived stromal cells” NCT07544537 ↗ |